| abstract |
The present invention relates to a novel compound, a pharmaceutical composition comprising the same, in particular its use for the manufacture of a medicament for the treatment of immunodeficiency feeding symptoms, and to a method of treating said condition comprising administering the compound. The compound is represented by general formula (I), which is further defined in the specification. |